Tucson, AZ, United States of America

Henry Mosberg


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henry Mosberg: Innovator in Cyclic Enkephalin Analogs

Introduction

Henry Mosberg is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of pharmacology through his innovative work on cyclic enkephalin analogs. His research focuses on developing compounds that enhance specificity for the delta receptor, which has implications for pain management and therapeutic applications.

Latest Patents

Henry Mosberg holds a patent for "Conformationally constrained cyclic enkephalin analogs with delta." This patent discloses novel compounds capable of binding with enhanced specificity to the delta receptor. The compounds are a series of cyclic, conformationally constrained analogs of enkephalins that display exceptional delta receptor specificity. The polypeptides of the present invention are defined by a specific formula, showcasing the innovative nature of his work.

Career Highlights

Throughout his career, Henry Mosberg has been dedicated to advancing the understanding of enkephalins and their potential therapeutic uses. His work has contributed to the development of new compounds that may lead to improved treatments for various conditions.

Collaborations

Henry Mosberg has collaborated with Victor J Hruby, a fellow researcher in the field. Their partnership has likely fostered advancements in the study of enkephalins and their analogs.

Conclusion

Henry Mosberg's contributions to the field of pharmacology through his innovative cyclic enkephalin analogs highlight his role as a significant inventor. His work continues to pave the way for future research and potential therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…